LIANY · LianBio · Executive Compensation
Market Cap
$4.21M
Shares
108.06M
Volume · Nov 2
9100
Avg daily vol (3M)
17.05K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ehong Gu | Interim Chief Financial Officer | Appointed | 2023-12-20 |
| Yi Larson | Chief Financial Officer | Resigned | 2023-12-20 |
| Adam Stone | Interim Chief Executive Officer | Appointed | 2023-12-19 |
| Yizhe Wang | member of the Company's board of directors | Resigned | 2023-12-19 |
| Yizhe Wang | Chief Executive Officer | Resigned | 2023-12-19 |
| Debra Yu | President and Chief Strategy Officer | Resigned | 2022-12-13 |
Leadership
- Adam Stone CEO, Board Member
- Ehong Gu CFO
- Konstantin Poukalov Board Member
- Neil Kumar Board Member
- Susan Silbermann Board Member
- Tassos Gianakakos Board Member
- Wei Wei Chen Board Member